Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F63X6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,230
Award facts
- Contract value 100% obligated
- $43,230.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $43,230.02 on December 16, 2025, for Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, represents a non-competitive set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Enbrel is a biologic disease-modifying antirheumatic drug used to treat autoimmune conditions including rheumatoid arthritis and other inflammatory diseases, commonly stocked within the federal medical supply chain to support military healthcare systems and veterans' medical needs.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare programs, AmerisourceBergen Drug Corp leverages this comprehensive contract vehicle to supply a broad range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support Defense Health Agency operations and other government healthcare systems worldwide. The company's established position as a primary vendor within the DLA's medical supply chain underscores its critical role in pharmaceutical procurement for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F63X6?
SPE2DR26F63X6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F63X6 worth?
The government has obligated $43,230 on SPE2DR26F63X6.
Is contract SPE2DR26F63X6 an order under another contract?
Yes. SPE2DR26F63X6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63X6 competed?
The extent of competition for SPE2DR26F63X6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award